Vanguard Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $174M | Buy |
|
|||||
|
2025
Q2 | $165M | Buy |
|
|||||
|
2025
Q1 | $160M | Sell |
|
|||||
|
2024
Q4 | $245M | Buy |
|
|||||
|
2024
Q3 | $326M | Sell |
|
|||||
|
2024
Q2 | $263M | Buy |
|
|||||
|
2024
Q1 | $225M | Buy |
|
|||||
|
2023
Q4 | $233M | Buy |
|
|||||
|
2023
Q3 | $219M | Buy |
|
|||||
|
2023
Q2 | $302M | Buy |
|
|||||
|
2023
Q1 | $233M | Buy |
|
|||||
|
2022
Q4 | $277M | Buy |
|
|||||
|
2022
Q3 | $258M | Buy |
|
|||||
|
2022
Q2 | $244M | Buy |
|
|||||
|
2022
Q1 | $261M | Sell |
|
|||||
|
2021
Q4 | $364M | Sell |
|
|||||
|
2021
Q3 | $412M | Buy |
|
|||||
|
2021
Q2 | $600M | Sell |
|
|||||
|
2021
Q1 | $466M | Buy |
|
|||||
|
2020
Q4 | $664M | Buy |
|
|||||
|
2020
Q3 | $240M | Sell |
|
|||||
|
2020
Q2 | $171M | Buy |
|
|||||
|
2020
Q1 | $121M | Buy |
|
|||||
|
2019
Q4 | $108M | Buy |
|
|||||
|
2019
Q3 | $93.4M | Buy |
|
|||||
|
2019
Q2 | $121M | Sell |
|
|||||
|
2019
Q1 | $153M | Buy |
|
|||||
|
2018
Q4 | $135M | Buy |
|
|||||
|
2018
Q3 | $105M | Buy |
|
|||||
|
2018
Q2 | $48.3M | Buy |
|
|||||
|
2018
Q1 | $22.3M | Buy |
|
|||||
|
2017
Q4 | $14.5M | Buy |
|